RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms . Braz. J. Pharm. Sci. [Internet]. 2013 Jun. 1 [cited 2024 May 3];49(2):359-66. Available from: https://www.revistas.usp.br/bjps/article/view/68967